The objective is to set-up the drug allergy assays by means of the integration of the component developments/ technologies (hardware, software, reagents, and methodologies) to yield a sensitive, selective, scalable, low-cost, and rapid IVD device. This work package, leaded by UPVLC, is based on the outcomes of WP1 to WP3.
The following specific objectives will be approached:
1. Evaluation of the sample treatment systems, detection modes, sensitivity, and specificity
2. Assay methodology development in non-integrated format
3. Integration and testing of the developed methodology and prototypes for the targeted drugs